Zydus Lifesciences pulled up by FDA over quality-control issues
The US health regulator, in a letter to the pharma company, accuses it of violating good manufacturing practices at its Vadodara plant.
15 September, 2024•2 min
0
15 September, 2024•2 min
0
More in Business
Business
Exclusive: Sunil Munjal invokes shares in Bira-linked entity
In another blow, founder Ankur Jain stands to lose further control over his troubled beer brand.
You may also like
Business
Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
